With an election upcoming on May 7, we have entered the approximately six-week period that we quaintly call “purdah”. For many, the word is a mystery. It can have the following definitions: 1) “ the practice among women in certain Muslim and Hindu societies of living in a separate room or behind a curtain, or of dressing in […]
The realities of life within the European Union came to roost in three specific ways last week. First, with Germany leading international opposition to the scheme, the UK was forced to slightly water down its Patent Box initiative that had become a key attraction for overseas entities, both in terms of locating business in the
The Week That Was in UK Health & Life Sciences– 17/11/14 Read More »
As usual in the life science universe, there were a number of “reactions” to market forces over the last week. Shire is to remain independent as AbbVie bows to the growing aversion to inversion strategies, a somewhat short-lived financial strategy that spawned a slew of major potential acquisitions for tax purposes including Pfizer’s earlier pursuit
The Week That Was, 27 Oct 2014 Read More »
